What do systematic reviews say?

Topical mydriatics vs intracameral mydriatics

Topical mydriatics probably leads to higher AE: participant‐reported ocular discomfort—month 1 compared with intracameral mydriatics (moderate certainty).

• Pharmacologic interventions for mydriasis in cataract surgery 2021 · Cochrane Headline outcomes only
  RR 2.51 [1.36, 4.65]
  1 study · 543 participants
  Moderate

Topical mydriatics vs intracameral mydriatics

Topical mydriatics showed no clear difference in AE: posterior capsule rupture compared with intracameral mydriatics (low certainty).

• Pharmacologic interventions for mydriasis in cataract surgery 2021 · Cochrane Headline outcomes only
  RR 0.32 [0.01, 7.83]
  1 study · 555 participants
  Low
• Pharmacologic interventions for mydriasis in cataract surgery 2021 · Cochrane Headline outcomes only
  RR 0.32 [0.01, 7.83]
  1 study · 555 participants
  Low

Psychological interventions vs usual care

It is very uncertain whether psychological intervention changes proportion of wounds completely healed at 3 months compared with standard care (very low certainty).

• Psychological interventions for treating foot ulcers, and preventing their recurrence, in people with diabetes 2021 · Cochrane Headline outcomes only
  RR 6.25
  2 studies · 76 participants
  Very low
• Psychological interventions for treating foot ulcers, and preventing their recurrence, in people with diabetes 2021 · Cochrane Headline outcomes only
  RR 0.59
  2 studies · 76 participants
  Very low

Psychological interventions vs Other Psychological Interventions

The review found no eligible studies for this question.

• Psychological interventions for treating foot ulcers, and preventing their recurrence, in people with diabetes 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Psychological interventions vs usual care

The review found no eligible studies for this question.

• Psychological interventions for treating foot ulcers, and preventing their recurrence, in people with diabetes 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Psychological interventions vs usual care

The review found no eligible studies for this question.

• Psychological interventions for treating foot ulcers, and preventing their recurrence, in people with diabetes 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Psychological interventions vs usual care

It is very uncertain whether psychological intervention changes number of foot ulcer recurrences at 1 year compared with standard care (very low certainty).

• Psychological interventions for treating foot ulcers, and preventing their recurrence, in people with diabetes 2021 · Cochrane Headline outcomes only
  RR 0.67
  2 studies · 54 participants
  Very low
• Psychological interventions for treating foot ulcers, and preventing their recurrence, in people with diabetes 2021 · Cochrane Headline outcomes only
  RR 0.63
  2 studies · 54 participants
  Very low

Psychological interventions vs Other Psychological Interventions

It is very uncertain whether psychological intervention changes proportion of wounds completely healed at 3 months compared with another psychological intervention (very low certainty).

• Psychological interventions for treating foot ulcers, and preventing their recurrence, in people with diabetes 2021 · Cochrane Headline outcomes only
  RR 2.33
  1 study · 16 participants
  Very low

Psychological interventions vs Other Psychological Interventions

• Psychological interventions for treating foot ulcers, and preventing their recurrence, in people with diabetes 2021 · Cochrane Headline outcomes only
  no estimate extracted
  2001 participants
  GRADE not reported

Psychological interventions vs Other Psychological Interventions

The review found no eligible studies for this question.

• Psychological interventions for treating foot ulcers, and preventing their recurrence, in people with diabetes 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Eculizumab vs placebo or alternative treatment

• Interventions for atypical haemolytic uraemic syndrome 2021 · Cochrane Headline outcomes only
  no estimate extracted
  100 participants
  Very low

Ravulizumab vs placebo or alternative treatment

• Interventions for atypical haemolytic uraemic syndrome 2021 · Cochrane Headline outcomes only
  no estimate extracted
  56 participants
  Very low

Ravulizumab vs placebo or alternative treatment

• Interventions for atypical haemolytic uraemic syndrome 2021 · Cochrane Headline outcomes only
  no estimate extracted
  56 participants
  Very low

Ravulizumab vs placebo or alternative treatment

• Interventions for atypical haemolytic uraemic syndrome 2021 · Cochrane Headline outcomes only
  no estimate extracted
  44 participants
  Very low

Ravulizumab vs placebo or alternative treatment

• Interventions for atypical haemolytic uraemic syndrome 2021 · Cochrane Headline outcomes only
  no estimate extracted
  58 participants
  Very low

Ravulizumab vs placebo or alternative treatment

• Interventions for atypical haemolytic uraemic syndrome 2021 · Cochrane Headline outcomes only
  no estimate extracted
  58 participants
  Very low

Eculizumab vs placebo or alternative treatment

• Interventions for atypical haemolytic uraemic syndrome 2021 · Cochrane Headline outcomes only
  no estimate extracted
  100 participants
  Very low

Eculizumab vs placebo or alternative treatment

• Interventions for atypical haemolytic uraemic syndrome 2021 · Cochrane Headline outcomes only
  no estimate extracted
  100 participants
  Very low

Eculizumab vs placebo or alternative treatment

• Interventions for atypical haemolytic uraemic syndrome 2021 · Cochrane Headline outcomes only
  no estimate extracted
  88 participants
  Very low

Eculizumab vs placebo or alternative treatment

• Interventions for atypical haemolytic uraemic syndrome 2021 · Cochrane Headline outcomes only
  no estimate extracted
  100 participants
  Very low